229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.53%
Revenue growth under 50% of VUZI's 27.27%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.65%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
8.59%
Positive EBIT growth while VUZI is negative. John Neff might see a substantial edge in operational management.
8.59%
Positive operating income growth while VUZI is negative. John Neff might view this as a competitive edge in operations.
9.28%
Positive net income growth while VUZI is negative. John Neff might see a big relative performance advantage.
12.50%
Positive EPS growth while VUZI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
9.37%
Positive diluted EPS growth while VUZI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.31%
Share reduction while VUZI is at 28.46%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.32%
Reduced diluted shares while VUZI is at 28.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.02%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
29.21%
OCF growth above 1.5x VUZI's 8.21%. David Dodd would confirm a clear edge in underlying cash generation.
20.12%
FCF growth 75-90% of VUZI's 23.97%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
1522.02%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
352.12%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
63.17%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
2606.56%
Positive long-term OCF/share growth while VUZI is negative. John Neff would see a structural advantage in sustained cash generation.
351.35%
5Y OCF/share CAGR above 1.5x VUZI's 77.15%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
39.13%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
7128.17%
Positive 10Y CAGR while VUZI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
438.73%
Positive 5Y CAGR while VUZI is negative. John Neff might view this as a strong mid-term relative advantage.
40.00%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
1888.57%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
273.49%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
59.44%
3Y equity/share CAGR 1.25-1.5x VUZI's 45.10%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
61.85%
AR growth is negative/stable vs. VUZI's 226.47%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
32.43%
We show growth while VUZI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.19%
Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-6.54%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
13.71%
Debt growth far above VUZI's 8.33%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
5.18%
R&D dropping or stable vs. VUZI's 18.69%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
10.81%
SG&A declining or stable vs. VUZI's 35.99%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.